ICU Medical
ICUI · NYSE · Healthcare · United States
Financials at a glance
Source: SEC XBRLAnnual
Quarterly · last 8
Revenue (FY2025)
$2.2B
Net margin
0.0%
ROE
0.0%
Revenue CAGR (2y)
-0.6%
EPS (FY2025)
0.03
Net profit (FY2025)
$732,000
Ask MarketChacha about ICUI
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Financials
Yearly
| Period | Revenue | Net profit | EPS | Net margin | ROE |
|---|---|---|---|---|---|
| FY2025 | $2.2B | $732,000 | 0.03 | 0.0% | 0.0% |
| FY2024 | $2.4B | $-117.7M | -4.83 | -4.9% | -6.0% |
| FY2023 | $2.3B | $-29.7M | -1.23 | -1.3% | -1.4% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| 2026Q2 | $551.7M | $19.1M | 0.76 | 3.5% |
| 2026Q1 | $530.2M | $30.1M | 1.20 | 5.7% |
| 2025Q3 | $537.0M | $-3.4M | -0.14 | -0.6% |
| 2025Q2 | $548.9M | $35.3M | 1.43 | 6.4% |
| 2025Q1 | $604.7M | $-15.5M | -0.63 | -2.6% |
| 2024Q3 | $589.1M | $-33.0M | -1.35 | -5.6% |
| 2024Q2 | $596.5M | $-21.4M | -0.88 | -3.6% |
| 2024Q1 | $566.7M | $-39.5M | -1.63 | -7.0% |
| 2023Q3 | $553.3M | $7.2M | 0.30 | 1.3% |
| 2023Q2 | $549.3M | $-9.9M | -0.41 | -1.8% |
| 2023Q1 | $568.6M | $-9.8M | -0.41 | -1.7% |
Figures as reported, in reporting currency. Source: SEC XBRL.
Filings & announcements
2026
- SEC8/6/2026material
- SEC8/6/2026
- SEC5/18/2026material
- SEC5/7/2026material
- SEC5/7/2026
- SEC2/20/2026material
- SEC2/19/2026material
- SEC2/19/2026
2025
- SEC11/6/2025material
- SEC11/6/2025
- SEC8/7/2025material
- SEC8/7/2025
In the news
- ICU Medical stock faces an 18.29 percent gap to USD 192.80 targetad-hoc-news.de · 10/17/2026
- ICU Medical is due to report November 5, 2026: what it means for ICU Medical stockad-hoc-news.de · 10/15/2026
- Medical Devices & Supplies - Cardiology, Neurology, Vascular Q2 Earnings: Merit Medical Systems (NASDAQ:MMSI) Simply the BestYahoo Finance · 10/15/2026
- Is ICU Medical (ICUI) Undervalued On Improving Infusion Growth And Easing Earnings Pressures?Simply Wall Street · 10/13/2026
- Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve CannabisTradingView · 10/12/2026
- Should Infusion Growth Require Action From ICU Medical (ICUI) Investors?Simply Wall Street · 10/10/2026
- 3 Medical Product Stocks Positioned to Ride on the Industry TailwindsThe Globe and Mail · 10/9/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.